Memphasys
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 14 May 2021
- Reported shorts
- 9.1K
- Shares on issue
- 759.774M
Memphasys (MEM) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $273.8KM (source: ASX (Markit))vs $3.7KM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$4.1MM (source: ASX (Markit))vs −$5.0MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.002T (source: Derived: trailing 12 months at year end)vs −$0.001 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- n/mFY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Appendix 4E and 2026 Annual Report, 31 Aug 2026
Memphasys Limited reported revenue of $274k for FY2026, a significant increase from $4k in FY2025, driven by commercial sales of the Felix™ System. The net loss narrowed by 18% to $4.1 million, with underlying EBITDA improving to -$3.2 million. No dividends were declared, and the company highlighted a material uncertainty regarding going concern.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −1,498.8%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (listed unit is not one ordinary share)
- P/E
- n/a (listed unit is not one ordinary share)
- P/B
- n/a (listed unit is not one ordinary share)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $273.8KM (source: ASX (Markit)) | $3.7KM (source: ASX (Markit)) | $60.0K | $15.4K |
| Gross profit | n/a | n/a | $1.6K | $9.2K |
| Operating income | n/a | n/a | −$5.2M | −$3.6M |
| EBITDA | n/a | n/a | −$3.4M | −$2.5M |
| EBIT | n/a | n/a | −$4.1M | −$3.1M |
| Interest expense | n/a | n/a | $318.7K | $316.8K |
| Pretax income | n/a | n/a | −$4.4M | −$3.4M |
| Tax | n/a | n/a | $0 | $0 |
| NPAT | −$4.1MM (source: ASX (Markit)) | −$5.0MM (source: ASX (Markit)) | −$4.4M | −$3.4M |
| Net interest income | n/a | n/a | −$417.1K | −$414.9K |
| EPS basic | −$0.002T (source: Derived: trailing 12 months at year end) | −$0.001 | −$0.002 | −$0.002 |
| EPS diluted | −$0.002T (source: Derived: trailing 12 months at year end) | −$0.001 | −$0.002 | −$0.002 |
| Shares | n/a | n/a | 1.38B | 1.00B |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report13 Oct 2026via asx_announcements
- Appendix 4E and 2026 Annual ReportAnnual Results31 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report16 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report17 Apr 2026via asx_announcements
- Appendix 4D - Half-year Financial Report - 31 December 2025Half Year Results27 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report22 Jan 2026via asx_announcements
- Memphasys Secures CE Mark Approval for Felix SystemFinancial Report31 Dec 2025via crawler
- 2025 AGM ResultsFinancial Report31 Dec 2025via crawler
- Felix Middle East Direct Sales StrategyFinancial Report31 Dec 2025via crawler
- Memphasys Implements Leadership RestructureFinancial Report31 Dec 2025via crawler
Showing 10 of 87 reports